OR4D2
gene geneOn this page
Summary
OR4D2 (olfactory receptor family 4 subfamily D member 2, HGNC:8294) is a protein-coding gene on chromosome 17q22, encoding Olfactory receptor 4D2 (P58180). Odorant receptor.
Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome.
Source: NCBI Gene 124538 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 52 total
- MANE Select transcript:
NM_001004707
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:8294 |
| Approved symbol | OR4D2 |
| Name | olfactory receptor family 4 subfamily D member 2 |
| Location | 17q22 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000255713 |
| Ensembl biotype | protein_coding |
| Entrez | 124538 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000545221, ENST00000641866
RefSeq mRNA: 1 — MANE Select: NM_001004707
NM_001004707
CCDS: CCDS32688
Canonical transcript exons
ENST00000545221 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002275991 | 58169638 | 58171116 |
| ENSE00003813200 | 58166982 | 58167053 |
Expression profiles
Bgee: expression breadth not_expressed, 0 present calls, max score 37.20.
Top tissues by expression
132 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| granulocyte | CL:0000094 | 35.77 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 35.77 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| bone marrow | UBERON:0002371 | 32.92 | gold quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| leukocyte | CL:0000738 | 30.92 | gold quality |
| monocyte | CL:0000576 | 30.67 | gold quality |
| tonsil | UBERON:0002372 | 30.60 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| calcaneal tendon | UBERON:0003701 | 29.06 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.04 | gold quality |
| urinary bladder | UBERON:0001255 | 28.67 | gold quality |
| gall bladder | UBERON:0002110 | 28.51 | gold quality |
| blood | UBERON:0000178 | 28.34 | gold quality |
| liver | UBERON:0002107 | 28.28 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| right coronary artery | UBERON:0001625 | 26.99 | gold quality |
| islet of Langerhans | UBERON:0000006 | 26.55 | gold quality |
| vermiform appendix | UBERON:0001154 | 26.42 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 25.89 | gold quality |
| placenta | UBERON:0001987 | 25.81 | gold quality |
| cortex of kidney | UBERON:0001225 | 25.47 | gold quality |
| uterine cervix | UBERON:0000002 | 25.32 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.13 |
Regulation
Is transcription factor: no
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Or4d2b | ENSMUSG00000093839 |
| mus_musculus | Or4d2 | ENSMUSG00000093920 |
| rattus_norvegicus | Or4d2 | ENSRNOG00000030521 |
| rattus_norvegicus | Or4d2b | ENSRNOG00000071576 |
Paralogs (130): OR1I1 (ENSG00000094661), OR12D3 (ENSG00000112462), OR7A10 (ENSG00000127515), OR7C2 (ENSG00000127529), OR7C1 (ENSG00000127530), OR1E2 (ENSG00000127780), OR1J1 (ENSG00000136834), OR1L4 (ENSG00000136939), OR4D1 (ENSG00000141194), OR4K1 (ENSG00000155249), OR3A3 (ENSG00000159961), OR7G1 (ENSG00000161807), OR1Q1 (ENSG00000165202), OR1K1 (ENSG00000165204), OR4K2 (ENSG00000165762), OR4D6 (ENSG00000166884), OR1F1 (ENSG00000168124), OR4K14 (ENSG00000169484), OR4K15 (ENSG00000169488), OR7G3 (ENSG00000170920), OR7G2 (ENSG00000170923), OR1M1 (ENSG00000170929), OR4D5 (ENSG00000171014), OR1L6 (ENSG00000171459), OR1L3 (ENSG00000171481), OR1L8 (ENSG00000171496), OR1N2 (ENSG00000171501), OR1N1 (ENSG00000171505), OR2AT4 (ENSG00000171561), OR1A1 (ENSG00000172146), OR1A2 (ENSG00000172150), OR4C11 (ENSG00000172188), OR4X2 (ENSG00000172208), OR4D9 (ENSG00000172742), OR10K1 (ENSG00000173285), OR1L1 (ENSG00000173679), OR7D4 (ENSG00000174667), OR4S2 (ENSG00000174982), OR4B1 (ENSG00000175619), OR4D11 (ENSG00000176200)
Protein
Protein identifiers
Olfactory receptor 4D2 — P58180 (reviewed: P58180)
Alternative names: B-lymphocyte membrane protein BC2009, Olfactory receptor OR17-24
All UniProt accessions (2): P58180, A0A126GWK0
UniProt curated annotations — full annotation on UniProt →
Function. Odorant receptor.
Subcellular location. Cell membrane.
Similarity. Belongs to the G-protein coupled receptor 1 family.
RefSeq proteins (1): NP_001004707* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000276 | GPCR_Rhodpsn | Family |
| IPR000725 | Olfact_rcpt | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
| IPR050427 | Olfactory_Receptors | Family |
Pfam: PF13853
UniProt features (19 total): topological domain 8, transmembrane region 7, chain 1, glycosylation site 1, disulfide bond 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P58180-F1 | 89.83 | 0.67 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (1): 97–189
Glycosylation sites (1): 5
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-381753 | Olfactory Signaling Pathway |
| R-HSA-9752946 | Expression and translocation of olfactory receptors |
MSigDB gene sets: 23 (showing top):
GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, KEGG_OLFACTORY_TRANSDUCTION, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON, chr17q22, GOMF_OLFACTORY_RECEPTOR_ACTIVITY, NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, MIKKELSEN_MCV6_ICP_WITH_H3K27ME3, GOBP_SENSORY_PERCEPTION_OF_SMELL, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION, NFKBIA_TARGET_GENES
GO Biological Process (4): signal transduction (GO:0007165), G protein-coupled receptor signaling pathway (GO:0007186), sensory perception of smell (GO:0007608), detection of chemical stimulus involved in sensory perception of smell (GO:0050911)
GO Molecular Function (2): G protein-coupled receptor activity (GO:0004930), olfactory receptor activity (GO:0004984)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| Sensory Perception | 1 |
| Olfactory Signaling Pathway | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transmembrane signaling receptor activity | 2 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| sensory perception of chemical stimulus | 1 |
| sensory perception of smell | 1 |
| detection of chemical stimulus involved in sensory perception | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| detection of chemical stimulus involved in sensory perception of smell | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
254 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| OR4D2 | ANO2 | Q9NQ90 | 420 |
| OR4D2 | GNG7 | O60262 | 419 |
| OR4D2 | PDE2A | O00408 | 399 |
| OR4D2 | VN1R4 | Q7Z5H5 | 355 |
| OR4D2 | CAMK2D | Q13557 | 349 |
| OR4D2 | VN1R2 | Q8NFZ6 | 323 |
| OR4D2 | SLC8A1 | P32418 | 311 |
| OR4D2 | VN1R1 | Q9GZP7 | 270 |
| OR4D2 | PRKG1 | P14619 | 246 |
| OR4D2 | TAS2R13 | Q9NYV9 | 245 |
| OR4D2 | TAS2R5 | Q9NYW4 | 228 |
| OR4D2 | TAS2R1 | Q9NYW7 | 227 |
| OR4D2 | OR51A7 | Q8NH64 | 225 |
| OR4D2 | TAS2R4 | Q9NYW5 | 220 |
| OR4D2 | TAS2R31 | P59538 | 215 |
| OR4D2 | TAS2R50 | P59544 | 215 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| OR4D2 | EEF1A2 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (4): OR4D2 (Affinity Capture-MS), EEF1A2 (Affinity Capture-MS), VMA21 (Affinity Capture-MS), OR4A15 (Affinity Capture-MS)
ESM2 similar proteins: A0A096LPK9, A0A0X1KG70, A6NHA9, A6NMZ5, P0C604, P0C623, P0C645, P0DN82, P58180, P58182, Q15615, Q60881, Q6IF82, Q8IXE1, Q8N0Y3, Q8NGA8, Q8NGB4, Q8NGB6, Q8NGC2, Q8NGC3, Q8NGD0, Q8NGD1, Q8NGD2, Q8NGD5, Q8NGE8, Q8NGF4, Q8NGF8, Q8NGF9, Q8NGI4, Q8NGI6, Q8NGJ0, Q8NGJ1, Q8NGL6, Q8NGM1, Q8NGN0, Q8NGN8, Q8NGX5, Q8NH05, Q8NH42, Q8NH49
Diamond homologs: A0A096LPK9, A0A0X1KG70, A6NHA9, A6NMZ5, O60412, O76099, O95013, P0C604, P0C623, P0C645, P0DN82, P23270, P23275, P58173, P58180, P58182, Q15615, Q60878, Q60881, Q60888, Q6IEV9, Q6IEY1, Q6IF82, Q7TQQ0, Q8IXE1, Q8N0Y3, Q8N628, Q8NGA8, Q8NGB2, Q8NGB4, Q8NGB6, Q8NGB8, Q8NGB9, Q8NGC2, Q8NGC3, Q8NGC4, Q8NGC6, Q8NGD0, Q8NGD1, Q8NGD2
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
52 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 47 |
| Likely benign | 5 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
256 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 17:58170320:T:TA | acceptor_gain | 0.7700 |
| 17:58170048:C:G | donor_gain | 0.7500 |
| 17:58170090:G:GA | donor_gain | 0.7400 |
| 17:58170299:T:TA | acceptor_gain | 0.6800 |
| 17:58170316:ATCCT:A | acceptor_gain | 0.6800 |
| 17:58170547:G:GG | donor_gain | 0.6300 |
| 17:58170239:T:A | acceptor_gain | 0.6200 |
| 17:58170323:T:TA | acceptor_gain | 0.6200 |
| 17:58170544:GCA:G | donor_gain | 0.6200 |
| 17:58170546:A:AG | donor_gain | 0.6200 |
| 17:58170204:A:G | acceptor_gain | 0.6000 |
| 17:58170263:G:GG | donor_gain | 0.6000 |
| 17:58170345:G:T | donor_gain | 0.6000 |
| 17:58170089:T:TA | donor_gain | 0.5900 |
| 17:58170249:CAAGA:C | acceptor_gain | 0.5900 |
| 17:58170410:TTCC:T | donor_gain | 0.5700 |
| 17:58170248:TCAAG:T | acceptor_gain | 0.5600 |
| 17:58170262:A:AG | donor_gain | 0.5600 |
| 17:58170326:TGCTG:T | acceptor_gain | 0.5600 |
| 17:58170560:G:GT | donor_gain | 0.5600 |
| 17:58169978:G:T | donor_gain | 0.5500 |
| 17:58170330:G:T | acceptor_gain | 0.5500 |
| 17:58170415:A:G | acceptor_gain | 0.5500 |
| 17:58170361:G:GT | donor_gain | 0.5400 |
| 17:58170357:G:T | donor_gain | 0.5300 |
| 17:58169978:G:GT | donor_gain | 0.5200 |
| 17:58170274:G:GT | donor_gain | 0.5200 |
| 17:58170321:G:A | acceptor_gain | 0.5200 |
| 17:58170329:TG:T | acceptor_gain | 0.5200 |
| 17:58170353:G:GT | donor_gain | 0.5100 |
AlphaMissense
2004 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 17:58170184:T:C | F177L | 0.894 |
| 17:58170186:C:A | F177L | 0.894 |
| 17:58170186:C:G | F177L | 0.894 |
| 17:58170157:T:C | F168L | 0.892 |
| 17:58170159:C:A | F168L | 0.892 |
| 17:58170159:C:G | F168L | 0.892 |
| 17:58170406:T:C | F251L | 0.876 |
| 17:58170408:C:A | F251L | 0.876 |
| 17:58170408:C:G | F251L | 0.876 |
| 17:58169689:T:C | F12L | 0.871 |
| 17:58169691:T:A | F12L | 0.871 |
| 17:58169691:T:G | F12L | 0.871 |
| 17:58170439:T:C | F262L | 0.817 |
| 17:58170441:C:A | F262L | 0.817 |
| 17:58170441:C:G | F262L | 0.817 |
| 17:58169737:T:C | F28L | 0.796 |
| 17:58169739:T:A | F28L | 0.796 |
| 17:58169739:T:G | F28L | 0.796 |
| 17:58170286:T:C | F211L | 0.795 |
| 17:58170288:C:A | F211L | 0.795 |
| 17:58170288:C:G | F211L | 0.795 |
| 17:58169959:T:C | F102L | 0.786 |
| 17:58169961:C:A | F102L | 0.786 |
| 17:58169961:C:G | F102L | 0.786 |
| 17:58169872:T:C | F73L | 0.774 |
| 17:58169874:C:A | F73L | 0.774 |
| 17:58169874:C:G | F73L | 0.774 |
| 17:58170009:G:A | M118I | 0.774 |
| 17:58170009:G:C | M118I | 0.774 |
| 17:58170009:G:T | M118I | 0.774 |
dbSNP variants (sampled 300 via entrez): RS1000337740 (17:58171485 C>A), RS1001204095 (17:58165719 T>C,G), RS1001867558 (17:58168796 C>T), RS1001897276 (17:58169129 G>A,C), RS1001907367 (17:58166401 T>A), RS1002382454 (17:58166186 C>A), RS1002505964 (17:58165785 C>T), RS1002570038 (17:58169310 A>C), RS1003051718 (17:58168942 G>C), RS1004433441 (17:58171189 G>C), RS1004708593 (17:58168164 C>G,T), RS1006380892 (17:58169601 A>G,T), RS1006410455 (17:58169403 C>T), RS1006600516 (17:58171391 A>G), RS1007597436 (17:58169969 A>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004361_6 | Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer | 8.000000e-06 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007970 | estrone measurement |
| EFO:0007972 | androstenedione measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | decreases methylation | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Diuron | decreases expression | 1 |
| Asbestos, Crocidolite | affects expression | 1 |
| Cadmium Chloride | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.